<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">nar</journal-id><journal-id journal-id-type="hwp">nar</journal-id><journal-title-group><journal-title>Nucleic Acids Research</journal-title></journal-title-group><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19073697</article-id><article-id pub-id-type="pmc">2632920</article-id><article-id pub-id-type="doi">10.1093/nar/gkn982</article-id><article-id pub-id-type="publisher-id">gkn982</article-id><article-categories><subj-group subj-group-type="heading"><subject>Computational Biology</subject></subj-group></article-categories><title-group><article-title>Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ortutay</surname><given-names>Csaba</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vihinen</surname><given-names>Mauno</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="aff" rid="AFF1"><sup>2</sup></xref><xref ref-type="corresp" rid="COR1">*</xref></contrib></contrib-group><aff id="AFF1"><sup>1</sup>Institute of Medical Technology, FI-33014 University of Tampere and <sup>2</sup>Tampere University Hospital, FI-33520 Tampere, Finland</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed: Tel: <phone>+358 3 3551 7735</phone>; Fax: <fax>+358 3 3551 7710</fax>; Email: <email>mauno.vihinen@uta.fi</email></corresp></author-notes><!--For NAR both ppub and collection dates generated for PMC processing 1/27/05 beck--><pub-date pub-type="collection"><month>2</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>10</day><month>12</month><year>2008</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>12</month><year>2008</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the							<pub-date pub-type="epub"/>. --><volume>37</volume><issue>2</issue><fpage>622</fpage><lpage>628</lpage><history><date date-type="received"><day>25</day><month>9</month><year>2008</year></date><date date-type="rev-recd"><day>19</day><month>11</month><year>2008</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; 2008 The Author(s)</copyright-statement><copyright-year>2008</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/">http://creativecommons.org/licenses/by-nc/2.0/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Disease gene identification is still a challenge despite modern high-throughput methods. Many diseases are very rare or lethal and thus cannot be investigated with traditional methods. Several <italic>in silico</italic> methods have been developed but they have some limitations. We introduce a new method that combines information about protein-interaction network properties and Gene Ontology terms. Genes with high-calculated network scores and statistically significant gene ontology terms based on known diseases are prioritized as candidate genes. The method was applied to identify novel primary immunodeficiency-related genes, 26 of which were found. The investigation uses the protein-interaction network for all essential immunome human genes available in the Immunome Knowledge Base and an analysis of their enriched gene ontology annotations. The identified disease gene candidates are mainly involved in cellular signaling including receptors, protein kinases and adaptor and binding proteins as well as enzymes. The method can be generalized for any disease group with sufficient information.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>Although genes related to diseases have already been determined over several decades and thousands of such genes are already known, it is still very difficult to find genes underlying a specific disorder. Traditionally, most studies have been based on linkage analysis of several affected families, which generally results a large locus or a few loci with numerous, even hundreds, of genes. Still, the identification of the disease gene is difficult and laborious as several difficulties can impede this approach. Many diseases are so rare that it is impossible to find enough families for linkage analysis. For example, in the recently discovered primary immunodeficiency (PID) caused by defective endosomal adaptor protein p14, only a single patient is known (<xref ref-type="bibr" rid="B1">1</xref>). A similar case arises when the symptoms of the disease are so severe that hardly any patients have siblings, such as in severe combined immunodeficiencies (SCIDs) (<xref ref-type="bibr" rid="B2">2</xref>).</p><p>Even if the disease-related locus is identified, the gene identification can fail, especially if the genomic region is large. Similar problems also impede modern genome-wide association studies (<xref ref-type="bibr" rid="B3">3</xref>). Due to all these challenges, several attempts have been made to identify candidate genes using <italic>in silico</italic> methods (<xref ref-type="bibr" rid="B4 B5 B6">4&#x02013;6</xref>). These approaches have been grouped in three categories (<xref ref-type="bibr" rid="B7">7</xref>). Some of the methods are sequence-based or they use other intrinsic properties of the genes like functional annotations (<xref ref-type="bibr" rid="B8">8</xref>). Others are based on gene expression patterns or other phenotypic properties (<xref ref-type="bibr" rid="B9">9</xref>). In the third category, the methods use some kind of interaction between the genes or their products as the basis of the predictions (<xref ref-type="bibr" rid="B10">10</xref>). The individual disease gene predictions usually apply one or two of these approaches, such as in the PhenoPred system (<xref ref-type="bibr" rid="B11">11</xref>) or SUSPECTS (<xref ref-type="bibr" rid="B12">12</xref>).</p><p>Most of the algorithms have been implemented locally, but there are also Internet-based services dedicated to disease gene predictions, and some are parts of more general servers that can help the process. For example, GFINDER works on a user-defined gene list (<xref ref-type="bibr" rid="B13">13</xref>). Among the results are overrepresented gene ontology (GO) terms and diseases, which have significant relatedness to the provided genes. Many of the disease gene prediction tools are denoted for prioritization, i.e. they try to identify genes in a starter set, which has a higher likelihood of being related to the target disease(s) than the rest of the set. Certain systems are open for the scientific community (<xref ref-type="bibr" rid="B14">14</xref>) and have been applied to cancers (<xref ref-type="bibr" rid="B15">15</xref>) and fetal alcohol syndrome (<xref ref-type="bibr" rid="B5">5</xref>), for example.</p><p>Primary immunodeficiencies impair the function of the immune system. Patients with these intrinsic defects have increased susceptibility to recurrent and persistent infections and may also have autoimmune and cancer-related symptoms (<xref ref-type="bibr" rid="B16 B17 B18">16&#x02013;18</xref>). Most PIDs are rare and the diagnosed patients for a condition are often randomly spread around the world, and thus linkage or genome-wide association studies analysis in these rare diseases is barely possible.</p><p>There are numerous different mechanisms behind PIDs. Several PIDs affect T- or B-cell functions and, when both cell types are affected, lead to SCIDs. Other PIDs affect the major histocompatibility complex (MHC), antibody production, lymphocyte apoptosis, phagocytosis, the complement cascade or the innate immune system. Detailed information about PIDs is available from the ImmunoDeficiency Resource (IDR, <ext-link ext-link-type="uri" xlink:href="http://bioinf.uta.fi/idr">http://bioinf.uta.fi/idr</ext-link>; 19). Altogether, there are over 200 PIDs (<xref ref-type="bibr" rid="B16">16</xref>) and 144 PID genes listed in the IDR.</p><p>With an exhaustive analysis of literature and databases, we identified altogether 847 genes and proteins that are crucial for the immune system and thus form the essential human immunome (<xref ref-type="bibr" rid="B20">20</xref>). These genes and proteins are involved in numerous functions, including cell surface recognition, transcription factors, DNA processing and adaptor proteins. System level analysis has been performed, e.g. for the evolutionary history of these genes (<xref ref-type="bibr" rid="B21">21</xref>), the emergence of immunity-related domains and gene ontologies (<xref ref-type="bibr" rid="B21">21</xref>), and the development of the interaction network of the immunome proteins during the evolution of the immune system (<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>).</p><p>GO terms (<xref ref-type="bibr" rid="B24">24</xref>) are used for systematic annotation of genes on three levels, namely biological processes (BP), cellular components (CC) and molecular functions (MF). GOs have been used, e.g. for grouping genes by their common properties and for elucidating the biological meaning of results in high-throughput experiments (<xref ref-type="bibr" rid="B25">25</xref>), such as with microarrays (<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>).</p><p>Protein-interaction networks have been reconstructed for several organisms by using modern high-throughput methods (<xref ref-type="bibr" rid="B28 B29 B30">28&#x02013;30</xref>). Analyses of these networks have revealed functionally important proteins (<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>). Different networks, ranging from social interactions (<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>) via protein&#x02013;protein interactions (<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>) to the spreading of epidemics (<xref ref-type="bibr" rid="B37">37</xref>) as well as human made networks like the Internet (<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>), have been shown to share similar characteristics, which suggests common organizing principles for their emergence (<xref ref-type="bibr" rid="B40">40</xref>).</p><p>Here, we present a novel method for disease gene identification and prioritization. Our approach combines information about protein-interaction networks and GO terms. The method was applied to PIDs and human immunome data to suggest new genes that might have relevance to primary immunodeficiencies.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Immunome genes and their interactions</title><p>Information about PID genes and immunodeficiencies was taken from the IDR (<xref ref-type="bibr" rid="B19">19</xref>). Human immune system-related proteins were collected from the Immunome database, a reference set of human immune system-related genes and proteins (<xref ref-type="bibr" rid="B21">21</xref>) recently integrated with our other immunome registries in the Immunome Knowledge Base (Ortutay and Vihinen, submitted for publication). Protein interactions were associated with the immunome proteins according to the Human Protein Reference Database (HPRD) (<xref ref-type="bibr" rid="B41">41</xref>). As only interactions between the immunome proteins were taken into account, no new nodes were added, but proteins without interactions were eliminated from the dataset. The final network contained 584 nodes of the 847 original ones, forming altogether 1349 interactions (<xref ref-type="bibr" rid="B22">22</xref>). Interactions that appeared more than once were simplified to single edges.</p></sec><sec><title>Degree, vulnerability and closeness centrality of the immunome proteins</title><p>Network property characteristics, vulnerability, closeness centrality and degree of the nodes were calculated using the igraph R library (<xref ref-type="bibr" rid="B42">42</xref>). The degree specifies the number of interactions of a protein.</p><p>Vulnerability is calculated using the global efficiency of the network. Efficiency quantifies the efficiency of the network in sending information between nodes, assuming that the efficiency between two nodes is proportional to the reciprocal of their distance (<xref ref-type="bibr" rid="B43">43</xref>). Global efficiency was calculated as follows:<disp-formula><graphic xlink:href="gkn982um1"/></disp-formula>where <italic>d<sub>ij</sub></italic> is the distance between the <italic>i</italic>th and <italic>j</italic>th nodes as the minimal number of edges on the shortest path between them and <italic>N</italic> is the total number of nodes in the network.</p><p>The vulnerability of a network was calculated using efficiency characteristics (<xref ref-type="bibr" rid="B44">44</xref>). The vulnerability, <italic>V<sub>i</sub></italic>, of a network associated with the <italic>i</italic>th node is <italic>V<sub>i</sub> = (E &#x02212; E<sub>i</sub>)/E</italic>, where <italic>E</italic> is the global efficiency of the network while <italic>E<sub>i</sub></italic> is the global efficiency of the network without the node <italic>i</italic> and all of its interactions. The overall vulnerability of the network is the value of the most vulnerable node, i.e. the largest loss in performance when a node is deleted from the network.</p><p>Closeness centrality marks how far or close a certain node is to all the others, so that it can be interpreted as how central the position of the protein is in the network (<xref ref-type="bibr" rid="B45">45</xref>). It is defined by the inverse of the average length of the shortest paths to/from all the other vertices in the graph:<disp-formula><graphic xlink:href="gkn982um2"/></disp-formula>where <italic>|V<sub>i</sub>|</italic> is the size of the reachable subnetwork from node <italic>i</italic> and <italic>d<sub>ij</sub></italic> is the distance between the <italic>i</italic>th and <italic>j</italic>th nodes.</p><p>To test the biological significance of these scores, we compared their distribution in essential immunome genes and for all the proteins of the immunome-interaction network. We used Mammalian Phenotype Ontologies (<xref ref-type="bibr" rid="B46">46</xref>) to define genes as essential when they caused embryonic, perinatal or neonatal lethality in mouse models (<xref ref-type="bibr" rid="B47">47</xref>) according to the Mouse Genome Database (<xref ref-type="bibr" rid="B48">48</xref>). The human orthologs of murine genes were considered as essential, when the murine gene was annotated with one of the following phenotypes: neonatal lethality (MP:0002058), embryonic lethality (MP:0002080), perinatal lethality (MP:0002081), postnatal lethality (MP:0002082), lethality-postnatal (MP:0005373), lethality-embryonic/perinatal (MP:0005374), embryonic lethality before implantation (MP:0006204), embryonic lethality before somite formation (MP:0006205) or embryonic lethality before turning of embryo (MP:0006206).</p></sec><sec><title>GO analysis</title><p>GO terms (<xref ref-type="bibr" rid="B24">24</xref>) were collected from the Immunome database for all the 847 genes in the essential immunome. Using topGO R library (<xref ref-type="bibr" rid="B49">49</xref>), we identified three sets of 50 genes from the immunome protein-interaction network, which had the highest degree, vulnerability or closeness centrality. These sets were compared to the whole dataset. We made independent analyses for vulnerability, closeness centrality and degree scores in combination with the &#x02018;biological process&#x02019;, &#x02018;cellular component&#x02019; and &#x02018;molecular function&#x02019; ontology terms, thus performing altogether nine analyses. We used Fisher's exact test for statistics and three methods for enrichment analysis of the GO terms in the significant group. The methods called &#x02018;classic&#x02019;, &#x02018;elim&#x02019; and &#x02018;weight&#x02019; have been described and compared in ref. (<xref ref-type="bibr" rid="B49">49</xref>). The &#x02018;classic&#x02019; method tends to rank general terms highly, whereas methods &#x02018;elim&#x02019; and &#x02018;weight&#x02019; are more balanced and prefer more specific terms. This is especially true for the &#x02018;weight&#x02019; method; therefore, in subsequent analyses, we used the <italic>P</italic> values from this method to evaluate the significance of the terms.</p><p>We also performed the analysis so that the 144 known PID genes from the IDR were considered as significant and were compared to all the immunome genes. We also identified the significant BP, CC and MF ontology terms for the PID-related genes.</p></sec><sec><title>Predicting PID-related candidate genes</title><p>The significant PID-related GO terms were combined with the results for the protein-interaction network-related scores in order to predict new PID-related genes. The lists of genes with the 50 highest vulnerability, closeness centrality or degree values were created. When combined, these lists contained 84 genes.</p><p>Another list was generated for genes containing significant PID-related GO terms. Significant GO terms (<italic>P</italic> &#x0003c; 0.05), which were annotated for at least three but not for more than 50 immunome genes, were chosen. This way, we managed to exclude too general and therefore uninformative terms like &#x02018;cell part&#x02019; (GO:0044464) and terms that appeared to be significant just by chance because of their low frequency, like &#x02018;cyclosporin A binding&#x02019; (GO:0016018), which was annotated for a single gene. The weight method was applied for enrichment analysis. This way, 54 significant GO terms were chosen from the three GO term categories. In total, 231 genes had these annotations.</p><p>To combine all the results, a Venn graph was drawn for the high-network score genes, the significant GO term-related genes and the known PID genes. Those genes that appeared among both the high score and the GO-related lists, but were not among the known PID-causing genes, were defined as PID candidate genes.</p></sec><sec><title>Performance evaluation of the method</title><p>To assess the performance of our approach to find PID genes, we have done the leave-one-out test. We rerun the method for 144 times (the number of known PID genes) by leaving one known PID gene out at time. First, the effect of the left out gene on the GO parameters was checked. Then, we tested whether the left out known PID gene was predicted to be disease-related. The performance test was implemented using the <italic>R</italic> statistical environment.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>We developed a novel method for candidate disease gene identification. The method combines information about an interaction network describing the relations of proteins under study with their GO annotations to prioritize disease gene candidates. The method, which can be used for any disease gene group provided there is sufficient protein interaction and GO data available, was applied to the human immunome to search for novel PID candidates.</p><sec><title>Protein-interaction network-related scores</title><p>Several parameters can be used to describe interaction networks. General but descriptive scores, degree, vulnerability and closeness centrality were calculated for 584 proteins present in the immunome protein-interaction network. Degree values, as expected, show a power-law distribution with a power-law exponent of 1.6. All three parameters show strong correlation, their pairwise Spearman's rank correlation coefficients are between 0.67 and 0.785. FYN oncogene related to SRC (FYN), lymphocyte-specific protein tyrosine kinase (LCK), Janus kinase 1 (JAK1), signal transducer and activator of transcription 1 (STAT1), receptor type protein tyrosine phosphatase C (PTPRC), CD4 antigen (CD4) and complement component 3 (C3) were among the top 15 proteins in all the three scorings.</p><p>The scores were used to describe the importance of the proteins in the interaction network. To test this hypothesis, we identified the genes in which mutations lead to early lethality in mouse models. We called these &#x02018;essential genes&#x02019;. Values for the three tested parameters are significantly higher for essential genes compared to other immunome genes (<xref ref-type="fig" rid="F1">Figure 1</xref>). Of the 144 PID-related genes, 84 were among the top 50 genes when results for the individual scores were combined. Known PID-related proteins LCK, STAT1, PTPRC and C3 appeared in the top 15 in all three score lists. The PID-related proteins have significantly higher degrees compared to the whole dataset (<italic>P</italic> = 2.57 &#x000d7; 10<sup>&#x02212;4</sup>).<fig id="F1" position="float"><label>Figure 1.</label><caption><p>Protein-interaction network-related scores for essential and immunome genes. An immunome gene was considered essential if mutation in the mouse ortholog causes early lethality. <italic>P</italic> values for the Kruskal&#x02013;Wallis rank sum test are shown on the plots. (<bold>A</bold>) Degree; (<bold>B</bold>) vulnerability; (<bold>C</bold>) connectivity.</p></caption><graphic xlink:href="gkn982f1"/></fig></p></sec><sec><title>Significant GO terms for the genes with the top 50 network scores</title><p>The enrichment of GO annotations for the immunome genes with the top 50 scores was identified. Signaling-related ontology terms dominated the &#x02018;biological process&#x02019; ontologies. &#x02018;Protein amino acid phosphorylation&#x02019; (GO:0006468) was the most significant in the case of all three scorings. Fifty-two genes in the protein-interaction network have this annotation. The calculated <italic>P</italic> values for those terms are between 4.6 &#x000d7; 10<sup>&#x02212;4</sup> and 8.2 &#x000d7; 10<sup>&#x02212;9</sup>. Also, a high number of regulation-related ontology terms, such as &#x02018;regulation of T-cell activation&#x02019; (GO:0050863) or &#x02018;positive regulation of interleukin-12 biosynthetic process&#x02019; (GO:0045084) appear in the dataset.</p><p>Most of the significant &#x02018;molecular function&#x02019; ontology terms were related to kinase activity and receptor activity. Significant &#x02018;cellular component&#x02019; terms were less informative, being either too general or annotated for just a few proteins. Sometimes, they were obviously important for immunology, like &#x02018;immunological synapse&#x02019; (GO:0001772) or &#x02018;interleukin-1 receptor complex&#x02019; (GO:0045323).</p></sec><sec><title>Significant GO terms for the PID-related genes</title><p>GO enrichment analysis was performed for the known PID genes. The most significant terms had close relationships with immunology. In the case of MF, proteolysis-related terms, like &#x02018;chymotrypsin activity&#x02019; (GO:0004263) and &#x02018;endopeptidase inhibitor activity&#x02019; (GO:0004866) are dominant. The significant CC ontology terms point to structures important for immunology, such as &#x02018;membrane attack complex&#x02019; (GO:0005579), where all seven proteins annotated with this term are PID genes, and thus the significance of this term is high (<italic>P</italic> value 3.6 &#x000d7; 10<sup>&#x02212;7</sup> with the weight method).</p></sec><sec><title>Genes with high-network scores and significant GO terms as predicted disease genes</title><p>We combined the gene lists for the high-network score genes and the significant PID-related GO terms in order to identify new potential PID genes (<xref ref-type="fig" rid="F2">Figure 2</xref>). Altogether, 84 genes were among the 50 highest scores, when results for degree, closeness centrality and vulnerability were combined. Twenty-two of these genes were already-known PID genes. Two hundred and thirty-one genes had GO terms significantly related to PID genes, and 74 of them were PID genes. Altogether, 83 of the 144 PID-related genes were selected either by the GO terms or high-network scores. Thirty-nine genes had both high scores and significant terms, 13 of which were PID-related. So, finally, we have a list of 26 suspected PID candidate genes (<xref ref-type="table" rid="T1">Table 1</xref>).<table-wrap id="T1" position="float"><label>Table 1.</label><caption><p>Identified PID candidate genes</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Symbol</th><th rowspan="1" colspan="1">Full name</th><th rowspan="1" colspan="1">GeneID</th><th rowspan="1" colspan="1">Known diseases</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><italic>CD4</italic></td><td rowspan="1" colspan="1">CD4 antigen (p55)</td><td rowspan="1" colspan="1"><italic>920</italic></td><td rowspan="1" colspan="1">186 940 CD4<sup>+</sup> lymphocyte deficiency</td></tr><tr><td rowspan="1" colspan="1"><italic>CD9</italic></td><td rowspan="1" colspan="1">CD9 antigen (p24)</td><td rowspan="1" colspan="1">928</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>CTSG</italic></td><td rowspan="1" colspan="1">cathepsin G</td><td rowspan="1" colspan="1">1511</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>FADD</italic></td><td rowspan="1" colspan="1">Fas-associating protein with death domain</td><td rowspan="1" colspan="1">8772</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>FYN</italic></td><td rowspan="1" colspan="1">Protein-tyrosine kinase fyn</td><td rowspan="1" colspan="1">2534</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>GZMB</italic></td><td rowspan="1" colspan="1">Granzyme B</td><td rowspan="1" colspan="1">3002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>IGF1R</italic></td><td rowspan="1" colspan="1">Insulin-like growth factor 1 receptor</td><td rowspan="1" colspan="1">3480</td><td rowspan="1" colspan="1">147 370 Intrauterine and postnatal growth retardation</td></tr><tr><td rowspan="1" colspan="1"><italic>IL2RB</italic></td><td rowspan="1" colspan="1">Interleukin 2 receptor, &#x003b2;</td><td rowspan="1" colspan="1">3560</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>INSR</italic></td><td rowspan="1" colspan="1">Insulin receptor</td><td rowspan="1" colspan="1">3643</td><td rowspan="1" colspan="1">610 549 Diabetes mellitus, insulin-resistant, with acanthosis nigricans</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">609 968 Hyperinsulinemic hypoglycemia</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">246 200 Leprechaunism</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">262 190 Rabson&#x02013;Mendenhall syndrome</td></tr><tr><td rowspan="1" colspan="1"><italic>IRAK1</italic></td><td rowspan="1" colspan="1">Interleukin-1 receptor-associated kinase 1</td><td rowspan="1" colspan="1">3654</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>ITGB1</italic></td><td rowspan="1" colspan="1">&#x003b2; 1 integrin</td><td rowspan="1" colspan="1">3688</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>JAK1</italic></td><td rowspan="1" colspan="1">Janus kinase 1</td><td rowspan="1" colspan="1">3716</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>JAK2</italic></td><td rowspan="1" colspan="1">Janus kinase 2</td><td rowspan="1" colspan="1">3717</td><td rowspan="1" colspan="1">600 880 Budd&#x02013;Chiari syndrome</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">601 626 Leukemia, acute myelogenous</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">254 450 Myelofibrosis, idiopathic</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">263 300 Myeloproliferative disorder with erythrocytosis&#x02014;polycythemia vera</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">187 950 Thrombocythemia, essential</td></tr><tr><td rowspan="1" colspan="1"><italic>KIT</italic></td><td rowspan="1" colspan="1">v-Kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog</td><td rowspan="1" colspan="1">3815</td><td rowspan="1" colspan="1">606 764 Gastrointestinal stromal tumor, somatic</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">273 300 Germ cell tumors</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">273 300 Mast cell leukemia&#x02014;mastocytosis with associated hematologic disorder&#x02014;piebaldism</td></tr><tr><td rowspan="1" colspan="1"><italic>LRP1</italic></td><td rowspan="1" colspan="1">Low-density lipoprotein-related protein 1</td><td rowspan="1" colspan="1">4035</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>MAPK14</italic></td><td rowspan="1" colspan="1">Mitogen-activated protein kinase 14</td><td rowspan="1" colspan="1">1432</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>PDGFRB</italic></td><td rowspan="1" colspan="1">Platelet-derived growth factor receptor, &#x003b2;-polypeptide</td><td rowspan="1" colspan="1">5159</td><td rowspan="1" colspan="1">131 440 Myelomonocytic leukemia, chronic&#x02014;myeloproliferative disorder with eosinophilia</td></tr><tr><td rowspan="1" colspan="1"><italic>RELA</italic></td><td rowspan="1" colspan="1">v-Rel reticuloendotheliosis viral oncogene homolog A</td><td rowspan="1" colspan="1">5970</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>RIPK1</italic></td><td rowspan="1" colspan="1">Receptor (TNFRSF)-interacting serine-threonine kinase 1</td><td rowspan="1" colspan="1">8737</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>SOCS1</italic></td><td rowspan="1" colspan="1">Suppressor of cytokine signaling 1</td><td rowspan="1" colspan="1">8651</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>STAT3</italic></td><td rowspan="1" colspan="1">Signal transducer and activator of transcription 3</td><td rowspan="1" colspan="1">6774</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>THY1</italic></td><td rowspan="1" colspan="1">Thy-1 cell surface antigen</td><td rowspan="1" colspan="1">7070</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>TRAF1</italic></td><td rowspan="1" colspan="1">TNF receptor-associated factor 1</td><td rowspan="1" colspan="1">7185</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>TRAF2</italic></td><td rowspan="1" colspan="1">TNF receptor-associated factor 2</td><td rowspan="1" colspan="1">7186</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>TYK2</italic></td><td rowspan="1" colspan="1">Tyrosine kinase 2</td><td rowspan="1" colspan="1">7297</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>XRCC5</italic></td><td rowspan="1" colspan="1">X-ray repair complementing defective repair in Chinese hamster cells 5</td><td rowspan="1" colspan="1">7520</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>For each genes, the HGNC approved symbol, full name, Entrez GeneID and OMIM code for known diseases is provided.</p></fn></table-wrap-foot></table-wrap><fig id="F2" position="float"><label>Figure 2.</label><caption><p>Identification of novel PID candidate genes by using information about the network properties, GO terms and known immunodeficiency genes. The grey area indicates the 26 candidate genes that have high-protein network scores and GO terms enriched in PID genes and which are not among already known PID genes.</p></caption><graphic xlink:href="gkn982f2"/></fig></p><p>We addressed the performance of the method by a statistical test. By using the leave-one-out method, all the 13 known PID genes with high-GO scores and network scores were identified as disease-related. The result is 100% correct for the high-score network and GO-enriched PID genes in <xref ref-type="fig" rid="F2">Figure 2</xref>. Thus, it is very likely that also the 26 predicted PID genes, which have high-network and GO scores, have relevance to immunodeficiencies.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Protein-interaction networks have been recently used in several studies targeting diseases (<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B51">51</xref>). The theory of scale-free networks and graph theoretical approaches has been applied to several areas including biological and medical networks. Networks for 867 human diseases and 1377 disease genes were constructed to study essential and disease genes and their role in the human interactome (<xref ref-type="bibr" rid="B47">47</xref>). Only 15 immunodeficiencies were included in this analysis. In another study based on a protein-interaction network (<xref ref-type="bibr" rid="B50">50</xref>), the clustering of disease genes was noticed in the interactome. A recent review (<xref ref-type="bibr" rid="B51">51</xref>) steps even further and discusses four possible areas where protein networks can be used in relationship with diseases, including identification of disease-related subnetworks and prediction of new disease genes.</p><p>In some studies, disease gene prioritization has been targeted by <italic>in silico</italic> methods. Protein-interaction networks have formed the basis for certain techniques. In these studies, the location of proteins in the interaction network has been revealed to determine if they are in a significant position in the network (<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B52">52</xref>). Important proteins are essential and therefore frequently found among disease genes (<xref ref-type="bibr" rid="B47">47</xref>). Other approaches have integrated protein-interaction information with other data sources to select candidate disease genes (<xref ref-type="bibr" rid="B53 B54 B55">53&#x02013;55</xref>). Our method combines the scores describing properties of a protein interaction network with GO terms, which provide information for protein functions, processes and localization.</p><p>We have shown that there is a relationship between the importance of proteins in the immunome-interaction network, as indicated by centrality scores, and GO terms. The vulnerability, closeness centrality and degree values were calculated for all 584 immunome proteins in the interaction network. The scores show strong correlations with each other. The scores were used as measures for the importance of proteins in the immunome network. As previously indicated (<xref ref-type="bibr" rid="B47">47</xref>), many important proteins have a high-degree value, their vulnerability is high and they also have high closeness centrality.</p><p>To test the biological relevance of the scores, we used them to analyze essential genes. Mutations in essential genes cause embryonic, perinatal or neonatal lethality in mouse models. Mutations in certain PID genes also cause lethality and, in some other PID genes, lead to very severe conditions (SCIDs). The three network scores were significantly higher for essential genes than for immunome genes in general.</p><p>In the next step, we identified GO terms that were enriched in the known PID genes. Many of these terms were related to signaling or regulation. In this analysis, we applied a recently introduced method (<xref ref-type="bibr" rid="B49">49</xref>), which has been shown to be capable of estimating the significance of overrepresented GO terms and was used to analyze microarray experiment data (<xref ref-type="bibr" rid="B56">56</xref>).</p><p>New PID candidate genes were defined as having ontology terms significantly associated with disease genes and the encoded proteins as having high-network scores. We identified 26 such genes that could lead to immunodeficiencies when mutated. Many of the detected candidate genes have numerous functions and several interaction partners. The biological functions and the relevance of the candidate genes for immunology are discussed in detail in <ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn982/DC1">Supplementary Data</ext-link>.</p><p>The power of our method became more apparent when two of the predicted candidate genes turned out to be known PID genes, but not yet annotated in the IDR version we used to identify known disease genes. The signal transducer and activator of transcription 3 (STAT3) (<xref ref-type="bibr" rid="B57">57</xref>) and tyrosine kinase 2 (TYK2) (<xref ref-type="bibr" rid="B58">58</xref>) are responsible for PIDs and involved in IL-6R-related responses to infections (<xref ref-type="bibr" rid="B59">59</xref>). In addition, genome-wide association studies have uncovered susceptibility genes (<xref ref-type="bibr" rid="B60">60</xref>). Among these is the TRAF1-C5 region (<xref ref-type="bibr" rid="B61">61</xref>), which contains one of our OID candidate genes TRAF1. Thus, experimental evidence supports our <italic>in silico</italic> predictions.</p><p>Our method uses information about interactions among the proteins of the human immunome and also their functional annotation. The immunome charts the genes and their products for immunological responses and thus includes the PID genes. In a similar way, this method can be generalized to any group of diseases and the related genes and proteins for which sufficient information is available.</p></sec><sec><title>SUPPLEMENTARY DATA</title><p><ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/cgi/content/full/gkn982/DC1">Supplementary Data</ext-link> are available at NAR Online.</p></sec><sec><title>FUNDING</title><p>We thank the Medical Research Fund of Tampere University Hospital and Academy of Finland for financial support.</p><p><italic>Conflict of interest statement</italic>. None declared.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>[Supplementary Data]</title></caption><media mimetype="text" mime-subtype="html" xlink:href="gkn982_index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="gkn982_1.pdf"/></supplementary-material></sec></body><back><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohn</surname><given-names>G</given-names></name><name><surname>Allroth</surname><given-names>A</given-names></name><name><surname>Brandes</surname><given-names>G</given-names></name><name><surname>Thiel</surname><given-names>J</given-names></name><name><surname>Glocker</surname><given-names>E</given-names></name><name><surname>Schaffer</surname><given-names>AA</given-names></name><name><surname>Rathinam</surname><given-names>C</given-names></name><name><surname>Taub</surname><given-names>N</given-names></name><name><surname>Teis</surname><given-names>D</given-names></name><name><surname>Zeidler</surname><given-names>C</given-names></name><etal/></person-group><article-title>A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14</article-title><source>Nat. Med.</source><year>2007</year><volume>13</volume><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">17195838</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Le Deist</surname><given-names>F</given-names></name><name><surname>Hacein-Bey-Abina</surname><given-names>S</given-names></name><name><surname>Andre Schmutz</surname><given-names>I</given-names></name><name><surname>Basile Gde</surname><given-names>S</given-names></name><name><surname>de Villartay</surname><given-names>JP</given-names></name><name><surname>Cavazzana-Calvo</surname><given-names>M</given-names></name></person-group><article-title>Severe combined immunodeficiency. A model disease for molecular immunology and therapy</article-title><source>Immunol. Rev.</source><year>2005</year><volume>203</volume><fpage>98</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">15661024</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teo</surname><given-names>YY</given-names></name></person-group><article-title>Common statistical issues in genome-wide association studies: a review on power, data quality control, genotype calling and population structure</article-title><source>Curr. Opin. Lipidol.</source><year>2008</year><volume>19</volume><fpage>133</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">18388693</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perocchi</surname><given-names>F</given-names></name><name><surname>Mancera</surname><given-names>E</given-names></name><name><surname>Steinmetz</surname><given-names>LM</given-names></name></person-group><article-title>Systematic screens for human disease genes, from yeast to human and back</article-title><source>Mol. Biosyst.</source><year>2008</year><volume>4</volume><fpage>18</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">18075670</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombard</surname><given-names>Z</given-names></name><name><surname>Tiffin</surname><given-names>N</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>Bajic</surname><given-names>VB</given-names></name><name><surname>Hide</surname><given-names>W</given-names></name><name><surname>Ramsay</surname><given-names>M</given-names></name></person-group><article-title>Computational selection and prioritization of candidate genes for fetal alcohol syndrome</article-title><source>BMC Genomics</source><year>2007</year><volume>8</volume><fpage>389</fpage><pub-id pub-id-type="pmid">17961254</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Iratxeta</surname><given-names>C</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Andrade-Navarro</surname><given-names>MA</given-names></name></person-group><article-title>Update of the G2D tool for prioritization of gene candidates to inherited diseases</article-title><source>Nucleic Acids Res.</source><year>2007</year><volume>35</volume><fpage>W212</fpage><lpage>W216</lpage><pub-id pub-id-type="pmid">17478516</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oti</surname><given-names>M</given-names></name><name><surname>Brunner</surname><given-names>HG</given-names></name></person-group><article-title>The modular nature of genetic diseases</article-title><source>Clin. Genet.</source><year>2007</year><volume>71</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">17204041</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shriner</surname><given-names>D</given-names></name><name><surname>Baye</surname><given-names>TM</given-names></name><name><surname>Padilla</surname><given-names>MA</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Vaughan</surname><given-names>LK</given-names></name><name><surname>Loraine</surname><given-names>AE</given-names></name></person-group><article-title>Commonality of functional annotation: a method for prioritization of candidate genes from genome-wide linkage studies</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>e26</fpage><pub-id pub-id-type="pmid">18263617</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sultan</surname><given-names>M</given-names></name><name><surname>Piccini</surname><given-names>I</given-names></name><name><surname>Balzereit</surname><given-names>D</given-names></name><name><surname>Herwig</surname><given-names>R</given-names></name><name><surname>Saran</surname><given-names>NG</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Reeves</surname><given-names>RH</given-names></name><name><surname>Yaspo</surname><given-names>ML</given-names></name></person-group><article-title>Gene expression variation in Down's syndrome mice allows prioritization of candidate genes</article-title><source>Genome Biol.</source><year>2007</year><volume>8</volume><fpage>R91</fpage><pub-id pub-id-type="pmid">17531092</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohler</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>S</given-names></name><name><surname>Horn</surname><given-names>D</given-names></name><name><surname>Robinson</surname><given-names>PN</given-names></name></person-group><article-title>Walking the interactome for prioritization of candidate disease genes</article-title><source>Am. J. Hum. Genet.</source><year>2008</year><volume>82</volume><fpage>949</fpage><lpage>958</lpage><pub-id pub-id-type="pmid">18371930</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radivojac</surname><given-names>P</given-names></name><name><surname>Peng</surname><given-names>K</given-names></name><name><surname>Clark</surname><given-names>WT</given-names></name><name><surname>Peters</surname><given-names>BJ</given-names></name><name><surname>Mohan</surname><given-names>A</given-names></name><name><surname>Boyle</surname><given-names>SM</given-names></name><name><surname>Mooney</surname><given-names>SD</given-names></name></person-group><article-title>An integrated approach to inferring gene-disease associations in humans</article-title><source>Proteins Struct. Funct. Bioinformatics</source><year>2008</year><volume>72</volume><fpage>1030</fpage><lpage>1037</lpage></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adie</surname><given-names>EA</given-names></name><name><surname>Adams</surname><given-names>RR</given-names></name><name><surname>Evans</surname><given-names>KL</given-names></name><name><surname>Porteous</surname><given-names>DJ</given-names></name><name><surname>Pickard</surname><given-names>BS</given-names></name></person-group><article-title>SUSPECTS: enabling fast and effective prioritization of positional candidates</article-title><source>Bioinformatics</source><year>2006</year><volume>22</volume><fpage>773</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">16423925</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceresa</surname><given-names>M</given-names></name><name><surname>Masseroli</surname><given-names>M</given-names></name><name><surname>Campi</surname><given-names>A</given-names></name></person-group><article-title>A web-enabled database of human gene expression controlled annotations for gene list functional evaluation</article-title><source>Conf. Proc. IEEE Eng. Med. Biol. Soc.</source><year>2007</year><volume>2007</volume><fpage>394</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">18001973</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornblad</surname><given-names>TA</given-names></name><name><surname>Elliott</surname><given-names>KS</given-names></name><name><surname>Jowett</surname><given-names>J</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name></person-group><article-title>Prioritization of positional candidate genes using multiple web-based software tools</article-title><source>Twin Res. Hum. Genet.</source><year>2007</year><volume>10</volume><fpage>861</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">18179399</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>ME</given-names></name><name><surname>Claremont</surname><given-names>M</given-names></name><name><surname>Major</surname><given-names>JE</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name><name><surname>Lash</surname><given-names>AE</given-names></name></person-group><article-title>Cancer genes: a gene selection resource for cancer genome projects</article-title><source>Nucleic Acids Res.</source><year>2007</year><volume>35</volume><fpage>D721</fpage><lpage>D726</lpage><pub-id pub-id-type="pmid">17088289</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ochs</surname><given-names>H</given-names></name><name><surname>Puck</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name></person-group><source>Primary Immunodeficiency Diseases: A Molecular and Genetic Approach</source><year>2006</year><edition>2nd</edition><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marodi</surname><given-names>L</given-names></name><name><surname>Notarangelo</surname><given-names>LD</given-names></name></person-group><article-title>Immunological and genetic bases of new primary immunodeficiencies</article-title><source>Nat. Rev. Immunol.</source><year>2007</year><volume>7</volume><fpage>851</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">17960151</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>Y</given-names></name><name><surname>Routes</surname><given-names>JM</given-names></name></person-group><article-title>Immunodeficiency overview</article-title><source>Prim. Care</source><year>2008</year><volume>35</volume><fpage>159</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">18206723</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samarghitean</surname><given-names>C</given-names></name><name><surname>V&#x000e4;liaho</surname><given-names>J</given-names></name><name><surname>Vihinen</surname><given-names>M</given-names></name></person-group><article-title>IDR knowledge base for primary immunodeficiencies</article-title><source>Immunome Res.</source><year>2007</year><volume>3</volume><fpage>6</fpage><pub-id pub-id-type="pmid">17394641</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortutay</surname><given-names>C</given-names></name><name><surname>Vihinen</surname><given-names>M</given-names></name></person-group><article-title>Immunome: a reference set of genes and proteins for systems biology of the human immune system</article-title><source>Cell Immunol.</source><year>2006</year><volume>244</volume><fpage>87</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">17434156</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortutay</surname><given-names>C</given-names></name><name><surname>Siermala</surname><given-names>M</given-names></name><name><surname>Vihinen</surname><given-names>M</given-names></name></person-group><article-title>Molecular characterization of the immune system: emergence of proteins, processes, and domains</article-title><source>Immunogenetics</source><year>2007</year><volume>59</volume><fpage>333</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">17294181</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortutay</surname><given-names>C</given-names></name><name><surname>Vihinen</surname><given-names>M</given-names></name></person-group><article-title>Efficiency of the immunome protein interaction network increases during evolution</article-title><source>Immunome Res.</source><year>2008</year><volume>4</volume><fpage>4</fpage><pub-id pub-id-type="pmid">18430195</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortutay</surname><given-names>C</given-names></name><name><surname>Siermala</surname><given-names>M</given-names></name><name><surname>Vihinen</surname><given-names>M</given-names></name></person-group><article-title>ImmTree: database of evolutionary relationships of genes and proteins in the human immune system</article-title><source>Immunome Res.</source><year>2007</year><volume>3</volume><fpage>4</fpage><pub-id pub-id-type="pmid">17376226</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Ball</surname><given-names>CA</given-names></name><name><surname>Blake</surname><given-names>JA</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Butler</surname><given-names>H</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Dolinski</surname><given-names>K</given-names></name><name><surname>Dwight</surname><given-names>SS</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Gene ontology: tool for the unification of biology. The gene ontology consortium</article-title><source>Nat. Genet.</source><year>2000</year><volume>25</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">10802651</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beissbarth</surname><given-names>T</given-names></name></person-group><article-title>Interpreting experimental results using gene ontologies</article-title><source>Methods Enzymol.</source><year>2006</year><volume>411</volume><fpage>340</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">16939799</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochs</surname><given-names>MF</given-names></name><name><surname>Peterson</surname><given-names>AJ</given-names></name><name><surname>Kossenkov</surname><given-names>A</given-names></name><name><surname>Bidaut</surname><given-names>G</given-names></name></person-group><article-title>Incorporation of gene ontology annotations to enhance microarray data analysis</article-title><source>Methods Mol. Biol.</source><year>2007</year><volume>377</volume><fpage>243</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">17634621</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaj</surname><given-names>S</given-names></name><name><surname>van Erk</surname><given-names>A</given-names></name><name><surname>van Haaften</surname><given-names>RI</given-names></name><name><surname>Evelo</surname><given-names>CT</given-names></name></person-group><article-title>Linking microarray reporters with protein functions</article-title><source>BMC Bioinformatics</source><year>2007</year><volume>8</volume><fpage>360</fpage><pub-id pub-id-type="pmid">17897448</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uetz</surname><given-names>P</given-names></name><name><surname>Giot</surname><given-names>L</given-names></name><name><surname>Cagney</surname><given-names>G</given-names></name><name><surname>Mansfield</surname><given-names>TA</given-names></name><name><surname>Judson</surname><given-names>RS</given-names></name><name><surname>Knight</surname><given-names>JR</given-names></name><name><surname>Lockshon</surname><given-names>D</given-names></name><name><surname>Narayan</surname><given-names>V</given-names></name><name><surname>Srinivasan</surname><given-names>M</given-names></name><name><surname>Pochart</surname><given-names>P</given-names></name><etal/></person-group><article-title>A comprehensive analysis of protein-protein interactions in <italic>Saccharomyces cerevisiae</italic></article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>623</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">10688190</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Middendorf</surname><given-names>M</given-names></name><name><surname>Ziv</surname><given-names>E</given-names></name><name><surname>Wiggins</surname><given-names>CH</given-names></name></person-group><article-title>Inferring network mechanisms: the <italic>Drosophila melanogaster</italic> protein interaction network</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>3192</fpage><lpage>3197</lpage><pub-id pub-id-type="pmid">15728374</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>DR</given-names></name><name><surname>Tomlins</surname><given-names>SA</given-names></name><name><surname>Varambally</surname><given-names>S</given-names></name><name><surname>Mahavisno</surname><given-names>V</given-names></name><name><surname>Barrette</surname><given-names>T</given-names></name><name><surname>Kalyana-Sundaram</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Chinnaiyan</surname><given-names>AM</given-names></name></person-group><article-title>Probabilistic model of the human protein-protein interaction network</article-title><source>Nat. Biotechnol.</source><year>2005</year><volume>23</volume><fpage>951</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">16082366</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estrada</surname><given-names>E</given-names></name></person-group><article-title>Virtual identification of essential proteins within the protein interaction network of yeast</article-title><source>Proteomics</source><year>2006</year><volume>6</volume><fpage>35</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16281187</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>DY</given-names></name><name><surname>Lin</surname><given-names>K</given-names></name></person-group><article-title>Prediction of yeast protein-protein interaction network: insights from the gene ontology and annotations</article-title><source>Nucleic Acids Res.</source><year>2006</year><volume>34</volume><fpage>2137</fpage><lpage>2150</lpage><pub-id pub-id-type="pmid">16641319</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaral</surname><given-names>LA</given-names></name><name><surname>Scala</surname><given-names>A</given-names></name><name><surname>Barthelemy</surname><given-names>M</given-names></name><name><surname>Stanley</surname><given-names>HE</given-names></name></person-group><article-title>Classes of small-world networks</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2000</year><volume>97</volume><fpage>11149</fpage><lpage>11152</lpage><pub-id pub-id-type="pmid">11005838</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>IA</given-names></name><name><surname>Padian</surname><given-names>NS</given-names></name><name><surname>Marlow</surname><given-names>C</given-names></name><name><surname>Aral</surname><given-names>SO</given-names></name></person-group><article-title>Determinants and consequences of sexual networks as they affect the spread of sexually transmitted infections</article-title><source>J. Infect. Dis.</source><year>2005</year><volume>191</volume><issue>Suppl 1</issue><fpage>S42</fpage><lpage>S54</lpage><pub-id pub-id-type="pmid">15627230</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Carey</surname><given-names>VJ</given-names></name><name><surname>Long</surname><given-names>L</given-names></name><name><surname>Falcon</surname><given-names>S</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name></person-group><article-title>Graphs in molecular biology</article-title><source>BMC Bioinformatics</source><year>2007</year><volume>8</volume><issue>Suppl 6</issue><fpage>S8</fpage><pub-id pub-id-type="pmid">17903289</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieroni</surname><given-names>E</given-names></name><name><surname>de la Fuente van Bentem</surname><given-names>S</given-names></name><name><surname>Mancosu</surname><given-names>G</given-names></name><name><surname>Capobianco</surname><given-names>E</given-names></name><name><surname>Hirt</surname><given-names>H</given-names></name><name><surname>de la Fuente</surname><given-names>A</given-names></name></person-group><article-title>Protein networking: insights into global functional organization of proteomes</article-title><source>Proteomics</source><year>2008</year><volume>8</volume><fpage>799</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">18297653</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeger</surname><given-names>MJ</given-names></name><name><surname>Pautasso</surname><given-names>M</given-names></name><name><surname>Holdenrieder</surname><given-names>O</given-names></name><name><surname>Shaw</surname><given-names>MW</given-names></name></person-group><article-title>Modelling disease spread and control in networks: implications for plant sciences</article-title><source>New Phytol.</source><year>2007</year><volume>174</volume><fpage>279</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">17388891</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>R</given-names></name><name><surname>Jeong</surname><given-names>H</given-names></name><name><surname>Barabasi</surname><given-names>AL</given-names></name></person-group><article-title>Error and attack tolerance of complex networks</article-title><source>Nature</source><year>2000</year><volume>406</volume><fpage>378</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">10935628</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xulvi-Brunet</surname><given-names>R</given-names></name><name><surname>Sokolov</surname><given-names>IM</given-names></name></person-group><article-title>Growing networks under geographical constraints</article-title><source>Phys. Rev. E Stat. Nonlinear Soft Matter Phys.</source><year>2007</year><volume>75</volume><fpage>046117</fpage></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barabasi</surname><given-names>AL</given-names></name><name><surname>Albert</surname><given-names>R</given-names></name></person-group><article-title>Emergence of scaling in random networks</article-title><source>Science</source><year>1999</year><volume>286</volume><fpage>509</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">10521342</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathivanan</surname><given-names>S</given-names></name><name><surname>Periaswamy</surname><given-names>B</given-names></name><name><surname>Gandhi</surname><given-names>TK</given-names></name><name><surname>Kandasamy</surname><given-names>K</given-names></name><name><surname>Suresh</surname><given-names>S</given-names></name><name><surname>Mohmood</surname><given-names>R</given-names></name><name><surname>Ramachandra</surname><given-names>YL</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name></person-group><article-title>An evaluation of human protein-protein interaction data in the public domain</article-title><source>BMC Bioinformatics</source><year>2006</year><volume>7</volume><issue>Suppl 5</issue><fpage>S19</fpage><pub-id pub-id-type="pmid">17254303</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csardi</surname><given-names>G</given-names></name><name><surname>Nepusz</surname><given-names>T</given-names></name></person-group><article-title>The igraph software package for complex network research</article-title><source>Int. J. Complex Syst.</source><year>2006</year><fpage>1695</fpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latora</surname><given-names>V</given-names></name><name><surname>Marchiori</surname><given-names>M</given-names></name></person-group><article-title>Efficient behavior of small-world networks</article-title><source>Phys. Rev. Lett.</source><year>2001</year><volume>87</volume><fpage>198701</fpage><pub-id pub-id-type="pmid">11690461</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gol&#x02019;dshtein</surname><given-names>V</given-names></name><name><surname>Koganov</surname><given-names>G</given-names></name><name><surname>Surdutovich</surname><given-names>G</given-names></name></person-group><article-title>Vulnerability and hierarchy of complex networks</article-title><source>Arxiv. Prepr. Cond.-Mater.</source><year>2004</year><fpage>0409298</fpage></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>L</given-names></name></person-group><article-title>Centrality in social networks: conceptual clarification</article-title><source>Social Networks</source><year>1979</year><volume>1</volume><fpage>215</fpage><lpage>239</lpage></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Goldsmith</surname><given-names>CA</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name></person-group><article-title>The Mammalian phenotype ontology as a tool for annotating, analyzing and comparing phenotypic information</article-title><source>Genome Biol.</source><year>2005</year><volume>6</volume><fpage>R7</fpage><pub-id pub-id-type="pmid">15642099</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>KI</given-names></name><name><surname>Cusick</surname><given-names>ME</given-names></name><name><surname>Valle</surname><given-names>D</given-names></name><name><surname>Childs</surname><given-names>B</given-names></name><name><surname>Vidal</surname><given-names>M</given-names></name><name><surname>Barabasi</surname><given-names>AL</given-names></name></person-group><article-title>The human disease network</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>8685</fpage><lpage>8690</lpage><pub-id pub-id-type="pmid">17502601</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eppig</surname><given-names>JT</given-names></name><name><surname>Blake</surname><given-names>JA</given-names></name><name><surname>Bult</surname><given-names>CJ</given-names></name><name><surname>Kadin</surname><given-names>JA</given-names></name><name><surname>Richardson</surname><given-names>JE</given-names></name></person-group><article-title>The mouse genome database (MGD): new features facilitating a model system</article-title><source>Nucleic Acids Res.</source><year>2007</year><volume>35</volume><fpage>D630</fpage><lpage>D637</lpage><pub-id pub-id-type="pmid">17135206</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexa</surname><given-names>A</given-names></name><name><surname>Rahnenfuhrer</surname><given-names>J</given-names></name><name><surname>Lengauer</surname><given-names>T</given-names></name></person-group><article-title>Improved scoring of functional groups from gene expression data by decorrelating GO graph structure</article-title><source>Bioinformatics</source><year>2006</year><volume>22</volume><fpage>1600</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">16606683</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>I</given-names></name><name><surname>Rzhetsky</surname><given-names>A</given-names></name><name><surname>Vitkup</surname><given-names>D</given-names></name></person-group><article-title>Network properties of genes harboring inherited disease mutations</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>4323</fpage><lpage>4328</lpage><pub-id pub-id-type="pmid">18326631</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ideker</surname><given-names>T</given-names></name><name><surname>Sharan</surname><given-names>R</given-names></name></person-group><article-title>Protein networks in disease</article-title><source>Genome Res.</source><year>2008</year><volume>18</volume><fpage>644</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">18381899</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oti</surname><given-names>M</given-names></name><name><surname>Snel</surname><given-names>B</given-names></name><name><surname>Huynen</surname><given-names>MA</given-names></name><name><surname>Brunner</surname><given-names>HG</given-names></name></person-group><article-title>Predicting disease genes using protein-protein interactions</article-title><source>J. Med. Genet.</source><year>2006</year><volume>43</volume><fpage>691</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">16611749</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aerts</surname><given-names>S</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name><name><surname>Maity</surname><given-names>S</given-names></name><name><surname>Van Loo</surname><given-names>P</given-names></name><name><surname>Coessens</surname><given-names>B</given-names></name><name><surname>De Smet</surname><given-names>F</given-names></name><name><surname>Tranchevent</surname><given-names>LC</given-names></name><name><surname>De Moor</surname><given-names>B</given-names></name><name><surname>Marynen</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>B</given-names></name><etal/></person-group><article-title>Gene prioritization through genomic data fusion</article-title><source>Nat. Biotechnol.</source><year>2006</year><volume>24</volume><fpage>537</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">16680138</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>RA</given-names></name><name><surname>Liu</surname><given-names>JY</given-names></name><name><surname>Feng</surname><given-names>LL</given-names></name><name><surname>Bryson-Richardson</surname><given-names>RJ</given-names></name><name><surname>Fatkin</surname><given-names>D</given-names></name><name><surname>Wouters</surname><given-names>MA</given-names></name></person-group><article-title>Analysis of protein sequence and interaction data for candidate disease gene prediction</article-title><source>Nucleic Acids Res.</source><year>2006</year><volume>34</volume><fpage>e130</fpage><pub-id pub-id-type="pmid">17020920</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lage</surname><given-names>K</given-names></name><name><surname>Karlberg</surname><given-names>EO</given-names></name><name><surname>Storling</surname><given-names>ZM</given-names></name><name><surname>Olason</surname><given-names>PI</given-names></name><name><surname>Pedersen</surname><given-names>AG</given-names></name><name><surname>Rigina</surname><given-names>O</given-names></name><name><surname>Hinsby</surname><given-names>AM</given-names></name><name><surname>Tumer</surname><given-names>Z</given-names></name><name><surname>Pociot</surname><given-names>F</given-names></name><name><surname>Tommerup</surname><given-names>N</given-names></name><etal/></person-group><article-title>A human phenome-interactome network of protein complexes implicated in genetic disorders</article-title><source>Nat. Biotechnol.</source><year>2007</year><volume>25</volume><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">17344885</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Hughes-Oliver</surname><given-names>JM</given-names></name><name><surname>Menius</surname><given-names>JA</given-names><suffix>Jr</suffix></name></person-group><article-title>Domain-enhanced analysis of microarray data using GO annotations</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><fpage>1225</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">17379692</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minegishi</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Morio</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Agematsu</surname><given-names>K</given-names></name><name><surname>Tsuchiya</surname><given-names>S</given-names></name><name><surname>Takada</surname><given-names>H</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>N</given-names></name><name><surname>Ariga</surname><given-names>T</given-names></name><etal/></person-group><article-title>Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity</article-title><source>Immunity</source><year>2006</year><volume>25</volume><fpage>745</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">17088085</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minegishi</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Tsuchiya</surname><given-names>S</given-names></name><name><surname>Tsuge</surname><given-names>I</given-names></name><name><surname>Takada</surname><given-names>H</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>N</given-names></name><name><surname>Ariga</surname><given-names>T</given-names></name><name><surname>Pasic</surname><given-names>S</given-names></name><name><surname>Stojkovic</surname><given-names>O</given-names></name><etal/></person-group><article-title>Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>1058</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">17676033</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bustamante</surname><given-names>J</given-names></name><name><surname>Boisson-Dupuis</surname><given-names>S</given-names></name><name><surname>Jouanguy</surname><given-names>E</given-names></name><name><surname>Picard</surname><given-names>C</given-names></name><name><surname>Puel</surname><given-names>A</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name></person-group><article-title>Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases</article-title><source>Curr. Opin. Immunol.</source><year>2008</year><volume>20</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">18083507</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xavier</surname><given-names>RJ</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name></person-group><article-title>Genome-wide association studies: a new window into immune-mediated diseases</article-title><source>Nat. Rev. Immunol.</source><year>2008</year><volume>8</volume><fpage>631</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">18654571</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plenge</surname><given-names>RM</given-names></name><name><surname>Seielstad</surname><given-names>M</given-names></name><name><surname>Padyukov</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>AT</given-names></name><name><surname>Remmers</surname><given-names>EF</given-names></name><name><surname>Ding</surname><given-names>B</given-names></name><name><surname>Liew</surname><given-names>A</given-names></name><name><surname>Khalili</surname><given-names>H</given-names></name><name><surname>Chandrasekaran</surname><given-names>A</given-names></name><name><surname>Davies</surname><given-names>LR</given-names></name><etal/></person-group><article-title>TRAF1-C5 as a risk locus for rheumatoid arthritis &#x02014;a genomewide study</article-title><source>N. Engl. J. Med.</source><year>2007</year><volume>357</volume><fpage>1199</fpage><lpage>1209</lpage><pub-id pub-id-type="pmid">17804836</pub-id></element-citation></ref></ref-list></back></article>